Same Indication

Osimertinib vs Rabeprazole

Osimertinib vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Osimertinib and Rabeprazole.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Osimertinib — 48 hours; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Osimertinib — C28H33N7O2; Rabeprazole — C18H21N3O3S.

Molecular Weight: Osimertinib — 499.6050 g/mol; Rabeprazole — 359.4440 g/mol.

Type: Osimertinib — Small molecule; Rabeprazole — Small molecule.